Exchange: NYSEMkt·Updated 04:18 AM EST

PLX Earnings

Latest Earnings Results: Q3 '26

Reported: Nov 10

Estimated EPS

-$0.02

Reported EPS

$0.05

Surprise

+350%

Estimated Rev

$12.42M

Reported Rev

$21.92M

Surprise

+76.53%

Protalix BioTherapeutics reported Q3 2026 total revenue of $21.93M, net income of $3.96M, and diluted EPS of $0.05; selling-goods revenue was $21.83M, up 23.5% year over year.

Generated by Stocktwits using AI and company-reported earnings data for Q3 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q4 '26
-$0.04
--
--
N/A
Q3 '26
-$0.02
$0.05
350.00%
BEAT
Q2 '26
-$0.01
$0.05
600.00%
BEAT
Q1 '26
-$0.01
$0.22
2300.00%
BEAT
Q4 '25
$0.04
-$0.06
-250.00%
MISSED

Advertisement|Remove ads.